FindTrial
Sign In

Effects of epidural anesthesia and analgesia on immune function and outcome of gastiric cancer

Effects of epidural anesthesia and analgesia on immune function and outcome of gastiric cancer: a randomised, prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17012939
Enrollment
Unknown
Registered
2017-10-11
Start date
2017-11-15
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative immune dysfunction

Interventions

EGA group:Epidural anesthesia
GA group:General anesthesia

Sponsors

Department of Anesthesiology, Cancer Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18-65 years old, ASA I-III grade, who have had gastric cancer surgery in hospital.

Exclusion criteria

Exclusion criteria: chemo-therapy history, white blood cell abnormal, no gastric cancer, transfusion were excluded from this project.

Design outcomes

Primary

MeasureTime frame
IL-2, 4, 6, 10 IFN-?;—

Countries

China

Contacts

Public ContactWang Yu

Cancer Hospital of Harbin Medical University

littlepigdiudiu@163.com+86 0451 86298029

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026